Immune system clues guide lighter chemo in breast cancer trial
Disease control
Recruiting now
This study tests a more personalized chemotherapy plan for women with early-stage triple-negative breast cancer. The treatment is adjusted based on immune system activity in the tumor and imaging results. The goal is to see if a lighter chemo can still be effective, reducing side…
Phase: PHASE2 • Sponsor: D'Or Institute for Research and Education • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC